PRAME Antikörper (AA 1-509) (FITC)

Produktnummer ABIN7159239

Produktdetails anti-PRAME Antikörper (FITC)

Target: PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Bindungsspezifität: AA 1-509

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRAME Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Melanoma antigen preferentially expressed in tumors protein (1-509AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu PRAME

Target: PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Andere Bezeichnung: PRAME (PRAME Produkte)

Hintergrund:

Background: Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. Prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.

Aliases: 4930534P07Rik antibody, Cancer/testis antigen 130 antibody, CT130 antibody, MAPE antibody, Melanoma antigen preferentially expressed in tumors antibody, OIP 4 antibody, OIP-4 antibody, OIP4 antibody, OPA interacting protein 4 antibody, Opa interacting protein OIP4 antibody, OPA-interacting protein 4 antibody, PRAME antibody, PRAME_HUMAN antibody, Preferentially expressed antigen in melanoma antibody, Preferentially expressed antigen of melanoma antibody, RP23-250F8.3 antibody

UniProt: P78395

Pathways: Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding